STW5 (Iberogast) vs placebo
Global symptoms of dyspepsia · patients with functional dyspepsia
1 finding from 1 review
- no estimate extracted5 studies · 814 participantsVery low
STW5 (Iberogast) showed no clear difference in global symptoms of dyspepsia (responders) compared with placebo (low certainty).
STW5 (Iberogast) showed no clear difference in adverse events Assessed clinically compared with placebo (low certainty).